Staphyloccous Aureus Bacteremia
Antimicrobial photodynamic therapy may treat nasal carriage of S. aureus
Antimicrobial photodynamic therapy may be an effective alternative to mupirocin in treating nasal carriage of Staphylococcus aureus in patients on maintenance hemodialysis, according to data in the American Journal of Kidney Diseases.
Staph remains leading SSTI, expert says
NEW YORK — Staphylococcus aureus remains the leading cause of skin and soft tissue infections, or SSTIs, according to a pediatric infectious diseases expert.
Single-dose lysin shows promise against S. aureus in phase 2 trial
Patients with Staphylococcus aureus who were treated with exebacase, a recombinantly produced lysin, achieved symptom resolution in half the time compared with participants who received placebo, researchers reported at IDWeek.
S aureus linked to increased mortality risk over time with change in infection source
For patients receiving maintenance hemodialysis, infection with Staphylococcus aureus bacteremia led to worsening clinical outcomes, including increased in mortality, in a 21-year period.